Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Frustaci

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
JCI Insight|October 18, 2019
Prelamin A mediates myocardial inflammation in dilated and HIV-associated cardiomyopathiesDaniel Brayson, Andrea Frustaci, Romina Verardo, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2011
Nε-lysine acetylation determines dissociation from GAP junctions and lateralization of connexin 43 in normal and dystrophic heartClaudia Colussi, Jessica Rosati, Stefania Straino, et al.
European Journal of Heart Failure|September 6, 2022
Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial DiseasesBettina Heidecker, Noa Dagan, Ran Balicer, et al.
European Journal of Heart Failure|May 21, 2026
Current state of knowledge on the epidemiology, aetiology, diagnosis, and management of heart involvement in eosinophilia. A Clinical Consensus Statement of the ESC Working Group on Myocardial & Pericardial DiseasesPetr Kuchynka, Antonio Brucato, Carsten Tschöpe, et al.
European Heart Journal|April 9, 2024
Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term RegistryAlida L P Caforio, Juan P Kaski, Juan R Gimeno, et al.
Giornale Italiano Di Cardiologia (2006)|November 24, 2020
[ANMCO/SIC Consensus document on the management of myocarditis]Manlio Cipriani, Marco Merlo, Domenico Gabrielli, et al.
ESC Heart Failure|August 9, 2020
ESC EORP Cardiomyopathy Registry: real-life practice of genetic counselling and testing in adult cardiomyopathy patientsTiina Heliö, Perry Elliott, Juha W Koskenvuo, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|February 1, 2005
[Fabry disease in Italy: first epidemiologic and collaborative study]Roberta Ricci, Mario Castorina, Mariangela Di Lillo, et al.
European Heart Journal|May 20, 2025
Myopericardial complications following COVID-19 disease and vaccination: a clinical consensus statement of the European Society of Cardiology Working Group on Myocardial and Pericardial DiseasesMassimo Imazio, Cristina Basso, Antonio Brucato, et al.
BMJ Open|October 11, 2020
Early indicators of disease progression in Fabry disease that may indicate the need for disease-specific treatment initiation: findings from the opinion-based PREDICT-FD modified Delphi consensus initiativeDerralynn A Hughes, Patricio Aguiar, Patrick B Deegan, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
JCI Insight|October 18, 2019
Prelamin A mediates myocardial inflammation in dilated and HIV-associated cardiomyopathiesDaniel Brayson, Andrea Frustaci, Romina Verardo, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2011
Nε-lysine acetylation determines dissociation from GAP junctions and lateralization of connexin 43 in normal and dystrophic heartClaudia Colussi, Jessica Rosati, Stefania Straino, et al.
European Journal of Heart Failure|September 6, 2022
Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial DiseasesBettina Heidecker, Noa Dagan, Ran Balicer, et al.
European Journal of Heart Failure|May 21, 2026
Current state of knowledge on the epidemiology, aetiology, diagnosis, and management of heart involvement in eosinophilia. A Clinical Consensus Statement of the ESC Working Group on Myocardial & Pericardial DiseasesPetr Kuchynka, Antonio Brucato, Carsten Tschöpe, et al.
European Heart Journal|April 9, 2024
Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term RegistryAlida L P Caforio, Juan P Kaski, Juan R Gimeno, et al.
Giornale Italiano Di Cardiologia (2006)|November 24, 2020
[ANMCO/SIC Consensus document on the management of myocarditis]Manlio Cipriani, Marco Merlo, Domenico Gabrielli, et al.
ESC Heart Failure|August 9, 2020
ESC EORP Cardiomyopathy Registry: real-life practice of genetic counselling and testing in adult cardiomyopathy patientsTiina Heliö, Perry Elliott, Juha W Koskenvuo, et al.
Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna|February 1, 2005
[Fabry disease in Italy: first epidemiologic and collaborative study]Roberta Ricci, Mario Castorina, Mariangela Di Lillo, et al.
European Heart Journal|May 20, 2025
Myopericardial complications following COVID-19 disease and vaccination: a clinical consensus statement of the European Society of Cardiology Working Group on Myocardial and Pericardial DiseasesMassimo Imazio, Cristina Basso, Antonio Brucato, et al.
BMJ Open|October 11, 2020
Early indicators of disease progression in Fabry disease that may indicate the need for disease-specific treatment initiation: findings from the opinion-based PREDICT-FD modified Delphi consensus initiativeDerralynn A Hughes, Patricio Aguiar, Patrick B Deegan, et al.
Pageof 12